Skip to main content

Cookies on the NHS England website

We’ve put some small files called cookies on your device to make our site work.

We’d also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site.

Let us know if this is OK. We’ll use a cookie to save your choice. You can read more about our cookies before you choose.

 

Your feedback matters and will make a difference. Help us understand your digital experience by taking our 10 minute survey. Your responses are completely anonymous. Start the survey.

  • Home
  • News
  • Publications
  • Statistics
  • Blogs
  • Events
  • Contact us
NHS England
  • About us
  • Our work
  • Commissioning
  • Get involved

Idebenone for treating people over 12 years of age with Leber’s Hereditary Optic Neuropathy

Document first published:
9 July 2020
Page updated:
22 July 2020
Topic:
Commissioning, Medicine, Specialised commissioning
Publication type:
Policy or strategy, Report

Document

Clinical commissioning policy: Idebenone for treating people over 12 years of age with Leber’s Hereditary Optic Neuropathy

Clinical commissioning policy: Idebenone for treating people over 12 years of age with Leber’s Hereditary Optic Neuropathy

  • PDF
  • 197 KB
  • 17 pages

Document

Clinical panel report January 2018: Idebenone for treating people over 12 years of age with Leber’s Hereditary Optic Neuropathy

Clinical panel report January 2018: Idebenone for treating people over 12 years of age with Leber’s Hereditary Optic Neuropathy

  • PDF
  • 137 KB
  • 3 pages

Document

Clinical panel report October 2018: Idebenone for treating people over 12 years of age with Leber’s Hereditary Optic Neuropathy

Clinical panel report October 2018: Idebenone for treating people over 12 years of age with Leber’s Hereditary Optic Neuropathy

  • PDF
  • 88 KB
  • 3 pages

Document

CPAG summary report: Idebenone for treating people over 12 years of age with Leber’s Hereditary Optic Neuropathy

CPAG summary report: Idebenone for treating people over 12 years of age with Leber’s Hereditary Optic Neuropathy

  • PDF
  • 93 KB
  • 8 pages

Document

Evidence review: Idebenone for treating people over 12 years of age with Leber’s Hereditary Optic Neuropathy

Evidence review: Idebenone for treating people over 12 years of age with Leber’s Hereditary Optic Neuropathy

  • PDF
  • 437 KB
  • 61 pages

Document

Consultation report: Idebenone for treating people over 12 years of age with Leber’s Hereditary Optic Neuropathy

Consultation report: Idebenone for treating people over 12 years of age with Leber’s Hereditary Optic Neuropathy

  • PDF
  • 50 KB
  • 4 pages

Document

Stakeholder engagement report: Idebenone for treating people over 12 years of age with Leber’s Hereditary Optic Neuropathy

Stakeholder engagement report: Idebenone for treating people over 12 years of age with Leber’s Hereditary Optic Neuropathy

  • PDF
  • 71 KB
  • 3 pages
  • Terms and conditions
  • Privacy and cookies
  • Social media moderation
  • Website feedback
  • Accessibility statement
  • Open Government Licence v3.0
  • Sign up to our email bulletins
  • Follow us on X
  • Follow us on Facebook
  • Find us on Instagram
  • Visit us on LinkedIn
  • Watch videos on YouTube
NHS website